Beitz JM (2014) Parkinson’s disease: a review. Front Biosci (Schol Ed) 6:65–74. https://doi.org/10.2741/S415

Article  PubMed  Google Scholar 

Cabreira V, Massano J (2019) Parkinson’s disease: clinical review and update. Acta Med Port 32:661–670. https://doi.org/10.20344/AMP.11978

Article  CAS  PubMed  Google Scholar 

Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol 106–107:17–32. https://doi.org/10.1016/J.PNEUROBIO.2013.04.004

Article  PubMed  Google Scholar 

Rosen B, Kurtishi A, Vazquez-Jimenez GR, Møller SG (2021) The intersection of Parkinson’s disease, viral infections, and COVID-19. Mol Neurobiol 58:4477–4486. https://doi.org/10.1007/S12035-021-02408-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefanou MI, Palaiodimou L, Bakola E, et al (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13. https://doi.org/10.1177/20406223221076890

Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8. https://doi.org/10.3389/FPHAR.2017.00661

Glaser T, Andrejew R, Oliveira-Giacomelli A et al (2020) Purinergic receptors in basal ganglia diseases: shared molecular mechanisms between Huntington’s and Parkinson’s disease. Neurosci Bull 36:1299–1314. https://doi.org/10.1007/S12264-020-00582-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bose B (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139(Suppl):216–231. https://doi.org/10.1111/JNC.13731

Article  CAS  PubMed  Google Scholar 

Roy D, Ghosh R, Dubey S et al (2021) Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci 48:9–24. https://doi.org/10.1017/CJN.2020.173

Article  PubMed  Google Scholar 

Cartella SM, Terranova C, Rizzo V et al (2021) Covid-19 and Parkinson’s disease: an overview. J Neurol 268:4415–4421. https://doi.org/10.1007/S00415-021-10721-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trist, Hare, KL D (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell 18. https://doi.org/10.1111/ACEL.13031

Percário S, Da Silva Barbosa A, Varela ELP, et al (2020) Oxidative stress in Parkinson’s disease: potential benefits of antioxidant supplementation. Oxid Med Cell Longev 2020. https://doi.org/10.1155/2020/2360872

Liy PM, Puzi NNA, Jose S, Vidyadaran S (2021) Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells. Exp Biol Med (Maywood) 246:2399–2406. https://doi.org/10.1177/1535370221997052

Article  CAS  PubMed  Google Scholar 

Antony PMA, Diederich NJ, Krüger R, Balling R (2013) The hallmarks of Parkinson’s disease. FEBS J 280:5981–5993. https://doi.org/10.1111/FEBS.12335

Article  CAS  PubMed  Google Scholar 

Filomeni G, De Zio D, Cecconi F (2015) Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ 22:377–388. https://doi.org/10.1038/CDD.2014.150

Article  CAS  PubMed  Google Scholar 

Achar A, Ghosh C (2020) COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance. Cells 9. https://doi.org/10.3390/CELLS9112360

Chaudhry ZL, Klenja D, Janjua N et al (2020) COVID-19 and Parkinson’s disease: shared inflammatory pathways under oxidative stress. Brain Sci 10:1–18. https://doi.org/10.3390/BRAINSCI10110807

Article  Google Scholar 

Chaudhry, Lavandero, Xie, et al (2020) Manipulation of ACE2 expression in COVID-19. Open Heart 7. https://doi.org/10.1136/OPENHRT-2020-001424

Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–150. https://doi.org/10.1038/NRNEUROL.2017.188

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397. https://doi.org/10.1016/S1474-4422(09)70062-6

Article  CAS  PubMed  Google Scholar 

Hirsch EC, Standaert DG (2021) Ten unsolved questions about neuroinflammation in Parkinson’s disease. Mov Disord 36:16–24. https://doi.org/10.1002/MDS.28075

Article  PubMed  Google Scholar 

Wang T, Shi C, Luo H et al (2022) Neuroinflammation in Parkinson’s disease: triggers, mechanisms, and immunotherapies. Neuroscientist 28:364–381. https://doi.org/10.1177/1073858421991066

Article  CAS  PubMed  Google Scholar 

Ginhoux F, Lim S, Hoeffel G et al (2013) Origin and differentiation of microglia. Front Cell Neurosci 7:46040. https://doi.org/10.3389/FNCEL.2013.00045/BIBTEX

Article  Google Scholar 

Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration 35:441–468. https://doi.org/10.1146/annurev-immunol-051116-052358

Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer’s disease. J Cell Biol 217:459–472. https://doi.org/10.1083/JCB.201709069

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wendimu MY, Hooks SB (2022) Microglia phenotypes in aging and neurodegenerative diseases. Cells 11:2091. https://doi.org/10.3390/CELLS11132091

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson’s disease. Int J Mol Sci 23. https://doi.org/10.3390/IJMS23084148

Zhang J, Wirtz S (2022) Does pyroptosis play a role in inflammasome-related disorders? International Journal of Molecular Sciences 2022, Vol 23. Page 10453(23):10453. https://doi.org/10.3390/IJMS231810453

Article  Google Scholar 

Mangan MSJ, Olhava EJ, Roush WR et al (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17(8):588–606. https://doi.org/10.1038/nrd.2018.97

Article  CAS  PubMed  Google Scholar 

Rathinam VAK, Fitzgerald KA (2016) Inflammasome complexes: emerging mechanisms and effector functions. Cell 165:792–800. https://doi.org/10.1016/J.CELL.2016.03.046

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu J, Wu H (2023) Structural mechanisms of NLRP3 inflammasome assembly and activation 41:301–316.  https://doi.org/10.1146/annurev-immunol-081022-021207

Dostert C, Pétrilli V, Van Bruggen R et al (1979) (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677. https://doi.org/10.1126/SCIENCE.1156995/SUPPL_FILE/DOSTERT.SOM.PDF

Article  ADS  Google Scholar 

Van RD, Verdijk R, Kuiken T (2015) The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 235:277–287. https://doi.org/10.1002/PATH.4461

Article  Google Scholar 

Pajares M, I Rojo A, Manda G, et al (2020) Inflammation in Parkinson’s disease: mechanisms and therapeutic implications. Cells 9. https://doi.org/10.3390/CELLS9071687

Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93:250–256. https://doi.org/10.1002/JMV.26232

Article  CAS  PubMed  Google Scholar 

Yang J, Ran M, Li H et al (2022) New insight into neurological degeneration: inflammatory cytokines and blood–brain barrier. Front Mol Neurosci 15:1013933. https://doi.org/10.3389/FNMOL.2022.1013933/BIBTEX

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. NeuroImmunoModulation 2:241–248. https://doi.org/10.1159/000097202

Article  CAS  PubMed  Google Scholar 

Achar A, Ghosh C (2020) COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance. Cells 9. https://doi.org/10.3390/CELLS9112360

Cilia R, Bonvegna S, Straccia G et al (2020) Effects of COVID-19 on Parkinson’s disease clinical features: a community-based case-control study. Mov Disord 35:1287–1292. https://doi.org/10.1002/mds.28170

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helmich RC, Bloem BR (2020) The Impact of the COVID-19 Pandemic on Parkinson’s disease: hidden sorrows and emerging opportunities. J Parkinsons Dis 10:351–354. https://doi.org/10.3233/JPD-202038

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirmani BF, Shapiro LA, Shetty AK (2021) Neurological and neurodegenerative disorders: novel concepts and treatment. Aging Dis 12:950. https://doi.org/10.14336/AD.2021.0530

Article  PubMed  PubMed Central  Google Scholar 

Hayes MT (2019) Parkinson’s disease and Parkinsonism. Am J Med 132:802–807. https://doi.org/10.1016/J.AMJMED.2019.03.001

Article  PubMed  Google Scholar 

Daneman R, Prat A (2015) The blood–brain barrier. Cold Spring Harb Perspect Biol 7. https://doi.org/10.1101/CSHPERSPECT.A020412

Fajgenbaum J (2020) Cytokine storm. N Engl J Med 383:2255–2273. https://doi.org/10.1056/NEJMRA2026131

Article  CAS  PubMed  PubMed Central